Functional Analysis of the Human N-Acetyltransferase 1 Major Promoter: Quantitation of Tissue Expression and Identification of Critical Sequence Elements
Authors:
- Xiaoyan ZhangXZXiaoyan Zhang
- Mark A. DollMDMark A. Doll
- J. Christopher StatesJSJ. Christopher States
- David F. BarkerDBDavid F. Barker
- David W. HeinDHDavid W. Hein
- 1 September 2007
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 35 (9) , 1649-1656
Abstract
Arylamine N-acetyltransferase 1 (NAT1) plays an important role in the biotransformation of xenobiotics, and genetic variants have been implicated in susceptibility to cancer and birth defects. A specific and quantitative reverse transcription-polymerase chain reaction assay for transcription from the major NAT1 promoter detected high expression with limited variability in human tissues. A 213-base pair (bp) minimal promoter was identified by transfection of luciferase reporter constructs into MCF-7 and HepG2 cell lines. Alignment of the 213-bp region with paralogous and orthologous promoters revealed two conserved region segments, one of which overlaps a 16-bp perfect palindrome. Transfection of luciferase constructs with artificial mutations in the minimal promoter defined two sites important for promoter function. One of these sites included a close match to the Sp1 transcription factor binding consensus sequence. Electrophoretic mobility shift assays (EMSAs), followed by competitive and supershift analyses, confirmed the Sp1 binding. Mutation of the highly conserved portion of the 16-bp palindrome reduced promoter activity more than 3-fold, and an EMSA shift was detected with an oligonucleotide, 200L29, which spans this segment. The 200L29 EMSA shift could not be competed by consensus Sp1 or AP-2 oligonucleotides, and may represent binding of a transcription factor that is common to N-acetyltransferase genes in humans and other species.Keywords
This publication has 41 references indexed in Scilit:
- Identification of N-Acetyltransferase 2 (NAT2) Transcription Start Sites and Quantitation of NAT2-Specific mRNA in Human TissuesDrug Metabolism and Disposition, 2007
- Classification of Breast Cancer Using Genetic Algorithms and Tissue MicroarraysClinical Cancer Research, 2006
- N-Acetyltransferase (Nat) 1 and 2 Expression in Nat2 Knockout MiceThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1Pharmacogenetics and Genomics, 2006
- Loss of function polymorphisms in NAT1 protect against spina bifidaHuman Genetics, 2006
- Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in miceBiochemical Journal, 2003
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- The Human Genome Browser at UCSCGenome Research, 2002
- BLAT—The BLAST-Like Alignment ToolGenome Research, 2002
- Site-directed mutagenesis by overlap extension using the polymerase chain reactionGene, 1989